Search research articles
Contact Us
Filters
Showing results (811-820 of 831) with videos related to
Page
of 84
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelines
Richard L Theriault, Robert W Carlson, Craig Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2019
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A Freedman, Rebecca S Gelman, Carey K Anders, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2014
Breast cancer version 3.2014
William J Gradishar, Benjamin O Anderson, Sarah L Blair, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions
Ryan J O Dowling, Joseph A Sparano, Pamela J Goodwin, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations
Ryan J O Dowling, Kevin Kalinsky, Daniel F Hayes, et al.
NPJ Breast Cancer
|
May 11, 2026
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
Yara Abdou, Mariya Rozenblit, Dario Trapani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
Natasha B Hunter, Heather A Parsons, Leslie Cope, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
E L Mayer, D Hlauschek, M Gnant, et al.
The Lancet. Oncology
|
July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Guillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
G Villacampa, N M Tung, S Pernas, et al.
Page
of 84
Search research articles
Search
Showing results (811-820 of 831) with videos related to
Sort By:
Page
of 84
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelines
Richard L Theriault, Robert W Carlson, Craig Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2019
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A Freedman, Rebecca S Gelman, Carey K Anders, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2014
Breast cancer version 3.2014
William J Gradishar, Benjamin O Anderson, Sarah L Blair, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions
Ryan J O Dowling, Joseph A Sparano, Pamela J Goodwin, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations
Ryan J O Dowling, Kevin Kalinsky, Daniel F Hayes, et al.
NPJ Breast Cancer
|
May 11, 2026
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
Yara Abdou, Mariya Rozenblit, Dario Trapani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
Natasha B Hunter, Heather A Parsons, Leslie Cope, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
E L Mayer, D Hlauschek, M Gnant, et al.
The Lancet. Oncology
|
July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Guillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
G Villacampa, N M Tung, S Pernas, et al.
Page
of 84